In the invertebrate liver fluke, Fasciola hepatica, there is evidence that 5-hydroxytryptamine (serotonin) increases glycolysis (1, 2), glycogenolysis (1), and phosphorylase activity (3). However, previous studies in mammalian liver, in vitro and in vivo, have yielded conflicting results concerning the effect of serotonin on hepatic glycogen content, hepatic phosphorylase, and blood glucose. So...